Intraoperative ketorolac may interact with patient-specific tumour genomics to modify recurrence risk in lung adenocarcinoma: an exploratory analysis.

[1]  Joseph R. Scarpa,et al.  Identifying Clear Cell Renal Cell Carcinoma Coexpression Networks Associated with Opioid Signaling and Survival , 2020, Cancer Research.

[2]  R. Casagrande,et al.  Contribution of Nrf2 Modulation to the Mechanism of Action of Analgesic and Anti-inflammatory Drugs in Pre-clinical and Clinical Stages , 2019, Front. Pharmacol..

[3]  H. Fernando,et al.  Implementing a thoracic enhanced recovery with ambulation after surgery program: key aspects and challenges. , 2018, Journal of thoracic disease.

[4]  P. Zhang,et al.  A double-edged function of DDX3, as an oncogene or tumor suppressor, in cancer progression (Review). , 2018, Oncology reports.

[5]  G. Joshi,et al.  Non-steroidal anti-inflammatory drugs in the oncological surgical population: beneficial or harmful? A systematic review of the literature , 2017, British journal of anaesthesia.

[6]  Angela N. Brooks,et al.  A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles , 2017, Cell.

[7]  Donavan T. Cheng,et al.  Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology. , 2015, The Journal of molecular diagnostics : JMD.

[8]  Steven J. M. Jones,et al.  Comprehensive molecular profiling of lung adenocarcinoma , 2014, Nature.

[9]  Tapan Behl,et al.  Reactivation of p53 gene by MDM2 inhibitors: A novel therapy for cancer treatment. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.